User profiles for C. G. Egan

Colin Gerard Egan

CE Medical Writing
Verified email at ce-medicalwriting.com
Cited by 1508

Mucoactive drugs

R Balsamo, L Lanata, CG Egan - European Respiratory Review, 2010 - Eur Respiratory Soc
Mucus hypersecretion is a clinical feature of severe respiratory diseases such as asthma,
cystic fibrosis and chronic obstructive pulmonary disease. Airway mucosal infection and/or …

Pathophysiology and pharmacological targets of VEGF in diabetic macular edema

S Fogli, S Mogavero, CG Egan, M Del Re… - Pharmacological …, 2016 - Elsevier
Diabetic macular edema (DME) is a serious condition that can cause blindness in diabetic
patients suffering from diabetic retinopathy (DR). Although vascular endothelial growth factor (…

Use of carvedilol in hypertension: an update

G Leonetti, CG Egan - Vascular Health and Risk Management, 2012 - Taylor & Francis
β-blockers are effective antihypertensive agents and, together with diuretics, have been the
cornerstone of pioneering studies showing their benefits on cardiovascular morbidity and …

[HTML][HTML] Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes

CG Egan, R Lavery, F Caporali, C Fondelli… - Diabetologia, 2008 - Springer
Aims/hypothesis In patients with type 2 diabetes, reduced levels of circulating endothelial
progenitor cells have been reported and these have been correlated with disease severity. In …

[HTML][HTML] Use of guselkumab for the treatment of moderate-to-severe plaque psoriasis: a 1 year real-life study

…, A Petruzzellis, D Silvaggio, CG Egan… - Journal of Clinical …, 2020 - mdpi.com
Little information is available from real-life studies evaluating the efficacy of guselkumab in
moderate-to-severe psoriasis. In this real-life study, we retrospectively examined a database …

[HTML][HTML] Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study

…, A Michielin, T Prandini, V Baffa, A Aghi, CG Egan… - Nutrients, 2021 - mdpi.com
Little information is available on the beneficial effects of cholecalciferol treatment in comorbid
patients hospitalized for COVID-19. The aim of this study was to retrospectively examine …

Epidemiology of frequently occurring skin diseases in Italian children from 2006 to 2012: a retrospective, population‐based study

…, L Cantarutti, E Peruzzi, CG Egan… - Pediatric …, 2015 - Wiley Online Library
Background Recent estimates indicate an increase in the prevalence of skin diseases in
children. Few large epidemiologic studies have examined prevalence trends in Europe. This …

Sevelamer use, vitamin K levels, vascular calcifications, and vertebral fractures in hemodialysis patients: results from the VIKI study

…, ML Brandi, S Ferrari, S Sella, CG Egan… - Journal of Bone and …, 2020 - academic.oup.com
Hyperphosphatemia is a risk factor for vascular calcifications (VCs), which are part of the
chronic kidney disease‐mineral and bone disorders (CKD‐MBD). Vitamin K‐dependent …

Sex‐related differences of clinical features in hidradenitis suppurativa: analysis of an Italian‐based cohort

…, G Monfrecola, M Napolitano, CG Egan… - Clinical and …, 2019 - academic.oup.com
The clinical characteristics associated with hidradenitis suppurativa (HS) severity are poorly
understood. In this study, 124 patients with HS from 6 Italian dermatology centres …

Clinical, ultrasound, and videodermatoscopy monitoring of psoriatic patients following biological treatment

…, F Lacarrubba, C Santagati, CG Egan… - Skin Research and …, 2016 - Wiley Online Library
Background and purpose Effective non‐invasive techniques to monitor plaque psoriasis
progression and treatment are desirable. The aim of the study was to evaluate changes in …